Clinical Trial Update: A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

An update on IMM-1-104's Phase 1/2a trial in advanced or metastatic solid tumors shows the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• IMM-1-104

Snippet

Sponsor: Immuneering Corporation | Conditions: Advanced Solid Tumor, Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING